At ACR Convergence 2025, researchers from Toronto and NYU reported that PsA patients starting GLP-1 receptor agonists had significant improvements in joint counts, CRP, pain scores, and DAPSA disease activity scores within one year of treatment. Whats interesting is that you dont seem to need a large dose to see these benefits
While these drugs offer a convenient option for many patients, we dont yet have long-term data about side effects or what happens when patients stop taking them
The medication was first developed by Novo Nordisk and has received multiple FDA approvals
Does Alli interact with the contraceptive pill
First-in-human trial of the safety, pharmacokinetics and immunogenicity of a PEGylated anti-CD40L antibody fragment (CDP7657) in healthy individuals and patients with systemic lupus erythematosus
This makes a comprehensive programwhich includes provider access, medication, and supportmuch more manageable over the long term